Allworth Financial’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Allworth Financial’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,429	Closed	-$4K	–	1674
2020 Q4	$4K	Hold	1,429	–	–	﹤0.01%	1056
2020 Q3	$4K	Hold	1,429	–	–	﹤0.01%	902
2020 Q2	$7K	Hold	1,429	–	–	﹤0.01%	813
2020 Q1	$7K	Hold	1,429	–	–	﹤0.01%	813
2019 Q4	$7K	Hold	1,429	–	–	﹤0.01%	719
2019 Q3	$11K	Buy	+1,429	New	+$11.2K	﹤0.01%	574

Other funds holding IDXG

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Allworth Financial's IDXG Position: Q1 2021 in Review

Allworth Financial sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q1 2021, closing a stake of 1,429 shares — an estimated $4K sold.

Allworth Financial first reported a position in IDXG in Q3 2019 and held it in 6 quarters. The position peaked at $11K in Q3 2019. 3 funds tracked by Wall St. Rank hold IDXG as of Q1 2021.

Allworth Financial reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Allworth Financial sold 1,429 Interpace Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $4K.
Allworth Financial first reported a position in Interpace Biosciences, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
Allworth Financial's Interpace Biosciences, Inc. Common Stock position peaked at $11K in Q3 2019.
3 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q1 2021.

Based on Allworth Financial's 13F filing for Q1 2021, filed 29 Apr 2021.